Europe Blood Glucose Device Market Stands at USD 7 Bn, Says Renub Research in Its New Report Recently Uploaded at

19 Aug 2016 • by Natalie Aster

LONDON – At present, the incidence of diabetes mellitus is following an upward trend in the European region. Furthermore, there are no any signs of slowing down in the upcoming years. Today, around 60 million people in Europe are living with diabetes, and this number is predicted to grow in the years ahead. Around 90% of diabetics in Europe suffer from type 2 diabetes.

Currently, the value of Europe’s blood glucose device market is estimated at over USD 7 billion. In the previous year, this regional market was dominated by Russia, the UK and Italy. Through 2020, the market share of Russia is anticipated to decline, whilst the UK market share is expected to increase. Other prominent country-wide markets for blood glucose devices in the European region include Spain and Germany.

Cutting-edge research report “Europe Blood Glucose Device (SMBG) (Test Strips, Lancet, Meter) Market & Forecast” developed by Renub Research presents a detailed analysis of the European market for blood glucose devices as well as contains 9 country-wide markets analyses. It discloses important facts on the historical and current market performance and also outlines future growth prospects through 2020. It includes a granular market segmentation analysis, reviews the key influencing factors, touches upon the major challenges and opportunities. Furthermore, forecasts through 2020 are given in this publication.

Many other in-demand reports by Renub Research are offered at this page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970